Bahamas vs IDA & IBRD total: Prevalence of hypertension, female
Bahamas
43.6%
in 2019
IDA & IBRD total
32.6%
in 2019
Bahamas rank
29th
IDA & IBRD total rank
27th
Prevalence of hypertension, female over time
- Bahamas
- IDA & IBRD total
How they compare
Bahamas currently reports 43.6% against 32.6% in IDA & IBRD total, a difference of 11.0%.
That makes Bahamas's figure about 1.3 times IDA & IBRD total's.
Across all 30 years both countries report, Bahamas has been ahead every year.
Bahamas ranks 29th and IDA & IBRD total ranks 27th of 192 countries.
Bahamas has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahamas | IDA & IBRD total | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.2% | 31.6% | 5.5% | Bahamas |
| 2000s | 39.9% | 33.2% | 6.8% | Bahamas |
| 2010s | 42.9% | 33.2% | 9.7% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, female, Bahamas or IDA & IBRD total?
- Bahamas, at 43.6% against 32.6% in IDA & IBRD total as of 2019.
- What is the difference in prevalence of hypertension, female between Bahamas and IDA & IBRD total?
- 11.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and IDA & IBRD total?
- 30 years are reported by both, from 1990 to 2019.
- How do Bahamas and IDA & IBRD total rank globally for prevalence of hypertension, female?
- Bahamas ranks 29th and IDA & IBRD total ranks 27th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, female (% of female adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.